Ligand-based vascular targeting of disease
- PMID: 17154429
- DOI: 10.1002/cmdc.200600181
Ligand-based vascular targeting of disease
Abstract
This review illustrates the basic principles of ligand-based vascular targeting and presents some of the most advanced results obtained in this field, not only in terms of biopharmaceuticals, which are currently being investigated in clinical and preclinical studies, but also in terms of enabling technologies that facilitate target and ligand discovery. Whereas most of the vascular targeting research activities have so far concentrated on tumoral angiogenesis, the development of non-oncological applications has recently gained momentum and is likely to become an important area of modern pharmaceutical research.
Similar articles
-
The impact of systems approaches on biological problems in drug discovery.Nat Biotechnol. 2004 Oct;22(10):1215-7. doi: 10.1038/nbt1004-1215. Nat Biotechnol. 2004. PMID: 15470453 No abstract available.
-
Anticancer drug discovery and development.Adv Exp Med Biol. 2008;610:19-42. doi: 10.1007/978-0-387-73898-7_3. Adv Exp Med Biol. 2008. PMID: 18593013 Review. No abstract available.
-
Perspective from the founding editors. Preface.Adv Drug Deliv Rev. 2013 Jan;65(1):3-4. doi: 10.1016/j.addr.2012.07.017. Epub 2012 Aug 17. Adv Drug Deliv Rev. 2013. PMID: 22940253 No abstract available.
-
Looking forward in pharmaceutical process chemistry.Science. 2009 Aug 7;325(5941):701-4. doi: 10.1126/science.1174501. Science. 2009. PMID: 19661417
-
Fragment-based drug design: combining philosophy with technology.Curr Opin Drug Discov Devel. 2007 Jul;10(4):422-9. Curr Opin Drug Discov Devel. 2007. PMID: 17659483 Review.
Cited by
-
Antibody-based delivery of interleukin-9 to neovascular structures: Therapeutic evaluation in cancer and arthritis.Exp Biol Med (Maywood). 2021 Apr;246(8):940-951. doi: 10.1177/1535370220981578. Epub 2021 Jan 21. Exp Biol Med (Maywood). 2021. PMID: 33475433 Free PMC article.
-
Tenascin-C in cardiovascular remodeling: potential impact for diagnosis, prognosis estimation and targeted therapy.Cell Adh Migr. 2015;9(1-2):90-5. doi: 10.1080/19336918.2014.1000075. Cell Adh Migr. 2015. PMID: 25562641 Free PMC article. Review.
-
Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP format antibodies.J Mol Histol. 2010 Feb;41(1):39-50. doi: 10.1007/s10735-010-9260-z. Epub 2010 Mar 16. J Mol Histol. 2010. PMID: 20232238
-
(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy.Eur J Nucl Med Mol Imaging. 2009 Aug;36(8):1235-44. doi: 10.1007/s00259-009-1096-y. Epub 2009 Mar 4. Eur J Nucl Med Mol Imaging. 2009. PMID: 19259661 Free PMC article.
-
Serum Liberation of Fetal Fibronectin Variants in Patients with Pulmonary Hypertension: ED-A+ Fn as Promising Novel Biomarker of Pulmonary Vascular and Right Ventricular Myocardial Remodeling.J Clin Med. 2021 Jun 9;10(12):2559. doi: 10.3390/jcm10122559. J Clin Med. 2021. PMID: 34207881 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical